Research programme: small molecule therapeutics - Janssen Biotech/Philogen
Alternative Names: Research programme: small molecules - Janssen Biotech/PhilogenLatest Information Update: 02 Dec 2021
At a glance
- Originator Janssen Biotech; Philogen
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified